COVID-19 Vaccine bulk supplier for pharma manufacturers

Covid-19 Vaccine Suppliers & Bulk Manufacturers

Available Forms: Vial for reconstitution (injectable, intramuscular)

Available Strengths: 30 µg per dose

Reference Brands: Comirnaty

Category: Nanoemulsion/Nanoparticles

COVID-19 Vaccine is available in Vial for reconstitution (injectable, intramuscular) and strengths such as 30 µg per dose. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, COVID-19 Vaccine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

COVID-19 Vaccine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description:

Comirnaty (Pfizer-BioNTech COVID-19 vaccine) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. FDA approval involved extensive clinical validation, safety monitoring, and efficacy data, while in the EU, CE marking certifies conformity with MDR standards. Both regions require validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial results, and quality management systems. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective COVID-19 vaccines supporting global health efforts and pandemic control.

Frequently Asked Questions

Yes, COVID-19 Vaccine is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, COVID-19 Vaccine is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Givosiran Infusion

Strength: 2.5 mg/kg IV infusion

Form: Intravenous infusion

Reference Brands: Givlaari

View Details
Patisiran Infusion

Strength: 0.3 mg/mL

Form: Intravenous (IV) infusion

Reference Brands: Onpattro

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.